Capecitabine vs 5‐FU‐containing regimens
Overall survival · people with advanced gastric cancer
Capecitabine showed no clear difference in overall Survival compared with 5‐FU‐containing regimens (moderate certainty).
1 finding from 1 review
- HR 0.94 [0.79, 1.11]5 studies · 732 participantsModerate